Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study

Abstract

Introduction Gastric peroral endoscopic myotomy (G-POEM) is a promising technique for treating refractory gastroparesis. We present the first double-blind randomized study comparing the clinical efficacy of G-POEM versus pyloric botulinum toxin injection (BTI).

Methods This randomized study, conducted in two expert centers, enrolled patients with refractory gastroparesis, medically managed for >6 months and confirmed by gastric emptying scintigraphy (GES), into two groups, G-POEM versus BTI, with follow-up of 1 year. The primary end point was the 3-month clinical efficacy, defined as a >1-point decrease in the mean Gastroparesis Cardinal Symptom Index (GCSI) score. Secondary end points were: 1-year efficacy, GES evolution, adverse events, and quality of life.

Results 40 patients (22 women; mean age 48.1 [SD 17.4]), with mean symptom duration of 5.8 (SD 5.7) years, were randomized. Etiologies included idiopathic (n=18), diabetes (n=11), postoperative (n=6), and mixed (n=4). G-POEM showed a higher 3-month clinical success than BTI (65% vs. 40%, respectively; P=0.10), along with non-significantly higher 1-year clinical success (60% vs. 40%, respectively) on intention-to-treat analysis. The GCSI decreased in both groups at 3 months and 1 year. Only three minor adverse events occurred in the G-POEM group. The GES improvement rate was 72% in the G-POEM group versus 50% in the BTI group (non-significant).

Conclusion G-POEM seems to have a higher clinically relevant success rate than BTI, but this was not statistically demonstrated. This study confirms the interest in treatments targeting the pylorus, either mechanically or chemically, for managing refractory gastroparesis.

Publication History

Received: 05 April 2023

Accepted after revision: 23 December 2023

Accepted Manuscript online:
23 December 2023

Article published online:
19 February 2024

• References

• 1 Schol J, Wauters L, Dickman R. et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. Neurogastroenterol Motil 2021; 33: 287-306 DOI: 10.1002/ueg2.12060. (PMID: 33939892)
• 2 Jung HK, Choung RS, Locke GR. et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225-1233
• 3 Wadhwa V, Mehta D, Jobanputra Y. et al. Healthcare utilization and costs associated with Gastroparesis. World J Gastroenterol 2017; 23: 4428-4436
• 4 Ye Y, Jiang B, Manne S. et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut 2021; 70: 644-653 DOI: 10.1136/gutjnl-2020-321277. (PMID: 32493829)
• 5 Cassilly DW, Wang YR, Friedenberg FK. et al. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 2008; 78: 144-151 DOI: 10.1159/000175836. (PMID: 19033686)
• 6 Revicki DA, Rentz AM, Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150 DOI: 10.1046/j.1365-2036.2003.01612.x. (PMID: 12848636)
• 7 Arts J, Holvoet L, Caenepeel P. et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258 DOI: 10.1111/j.1365-2036.2007.03467.x. (PMID: 17944739)
• 8 Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12 DOI: 10.1016/j.cgh.2010.09.022. (PMID: 20951838)
• 9 Lal N, Livemore S, Dunne D. et al. Gastric electrical stimulation with the Enterra System: a systematic review. Gastroenterol Res Pract 2015; 2015: 762972
• 10 Hasler WL. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009; 21: 229-243 DOI: 10.1111/j.1365-2982.2009.01277.x. (PMID: 19254353)
• 11 Levinthal DJ, Bielefeldt K. Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis. Auton Neurosci 2017; 202: 45-55 DOI: 10.1016/j.autneu.2016.03.004. (PMID: 27085627)
• 12 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925 DOI: 10.1016/0016-5085(86)90262-3. (PMID: 3699409)
• 13 Nguyen LA, Snape WJ. Clinical presentation and pathophysiology of gastroparesis. Gastroenterol Clin North Am 2015; 44: 21-30 DOI: 10.1016/j.gtc.2014.11.003. (PMID: 25667020)
• 14 Parkman HP, Pasricha PJ. Improving our understanding of gastroparesis. Gastroenterol Clin North Am 2015; 44: xv-xvi DOI: 10.1016/j.gtc.2014.12.001. (PMID: 25667034)
• 15 Friedenberg FK, Palit A, Parkman HP. et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423 DOI: 10.1111/j.1572-0241.2007.01676.x. (PMID: 18070232)
• 16 Ukleja A, Tandon K, Shah K. et al. Endoscopic botox injections in therapy of refractory gastroparesis. World J Gastrointest Endosc 2015; 7: 790-798 DOI: 10.4253/wjge.v7.i8.790. (PMID: 26191343)
• 17 Bromer MQ, Friedenberg F, Miller LS. et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833-839 DOI: 10.1016/s0016-5107(05)00328-7. (PMID: 15933684)
• 18 Weusten BLAM, Barret M, Bredenoord AJ. et al. Endoscopic management of gastrointestinal motility disorders – Part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52: 498-515
• 19 Shlomovitz E, Pescarus R, Cassera MA. et al. Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 2015; 29: 543-551
• 20 Chaves DM, de Moura EGH, Mestieri LHM. et al. Endoscopic pyloromyotomy via a gastric submucosal tunnel dissection for the treatment of gastroparesis after surgical vagal lesion. Gastrointest Endosc 2014; 80: 164 DOI: 10.1016/j.gie.2014.03.045. (PMID: 24836745)
• 21 Khashab MA, Besharati S, Ngamruengphong S. et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video). Gastrointest Endosc 2015; 82: 1106-1109
• 22 Gonzalez JM, Benezech A, Vitton V. et al. G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 2017; 46: 364-370
• 23 Kahaleh M, Gonzalez J-M, Xu M-M. et al. Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience. Endoscopy 2018; 50: 1053-1058 DOI: 10.1055/a-0596-7199. (PMID: 29649841)
• 24 Mekaroonkamol P, Shah R, Cai Q. Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide. World J Gastroenterol 2019; 25: 909-922 DOI: 10.3748/wjg.v25.i8.909. (PMID: 30833798)
• 25 Ragi O, Jacques J, Branche J. et al. One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: A French multicenter study. Endoscopy 2021; 53: 480-490 DOI: 10.1055/a-1205-5686. (PMID: 32575130)
• 26 Yan J, Tan Y, Zhou B. et al. Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis. Rev Esp Enferm Dig 2020; 112: 219-228 DOI: 10.17235/reed.2020.6559/2019. (PMID: 32081015)
• 27 Aghaie Meybodi M, Qumseya B, Shakoor D. et al. Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2019; 07: E322-E329
• 28 Vosoughi K, Ichkhanian Y, Benias P. et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2022; 71: 25-33
• 29 Martinek J, Hustak R, Mares J. et al. Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial. Gut 2022; 71: 2170-2178 DOI: 10.1136/gutjnl-2022-326904. (PMID: 35470243)
• 30 Abell TL, Camilleri M, Donohoe K. et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 2008; 36: 44-54 DOI: 10.1111/j.1572-0241.2007.01636.x. (PMID: 18028513)
• 31 Vosoughi K, Ichkhanian Y, Benias P. et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2022; 71: 25-33
• 32 DiBaise JK, Patel N, Noelting J. et al. The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing. Neurogastroenterol Motil 2016; 28: 234-242
• 33 Parkman HP, Hallinan EK, Hasler WL. et al. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Neurogastroenterol Motil 2017; 29 DOI: 10.1111/nmo.12981.
• 34 McCallum RW, Snape W, Brody F. et al. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8: 947-954
• 35 Rodriguez J, Strong AT, Haskins IN. et al. Per-oral pyloromyotomy (POP) for medically refractory gastroparesis. Ann Surg 2018; 268: 421-430 DOI: 10.1097/SLA.0000000000002927. (PMID: 30004920)
• 36 Gonzalez J, Lestelle V, Benezech A. et al. Gastric per-oral endoscopic myotomy with antro-pyloro-myotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video). Gastrointest Endosc 2017; 85: 132-139
• 37 Spadaccini M, Maselli R, Chandrasekar VT. et al. Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc 2020; 91: 746-752.e5
• 38 Thomas A, de Souza Ribeiro B, Malespin M. et al. Botulinum toxin as a treatment for refractory gastroparesis: a literature review. Curr Treat Options Gastroenterol 2018; 16: 479-488
• 39 Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986; 91: 94-99 DOI: 10.1016/0016-5085(86)90444-0. (PMID: 3710086)